Works by Peng, Cheng‐Yuan

Results: 90

Ropeginterferon alfa‐2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy.

Published in:

JGH Open, 2021, v. 5, n. 8, p. 929, doi. 10.1002/jgh3.12613

By:

Lin, Hsien‐Hong;
Hsu, Shih‐Jer;
Lu, Sheng‐Nan;
Chuang, Wan‐Long;
Hsu, Chao‐Wei;
Chien, Rong‐Nan;
Yang, Sien‐Sing;
Su, Wei‐Wen;
Wu, Jaw‐Ching;
Lee, Tzong‐Hsi;
Peng, Cheng‐Yuan;
Tseng, Kuan‐Chiao;
Qin, Albert;
Huang, Yi‐Wen;
Chen, Pei‐Jer

Publication type:

Article

Does diabetes mellitus with or without gallstones increase the risk of gallbladder cancer? Results from a population-based cohort study.

Published in:

Journal of Gastroenterology, 2013, v. 48, n. 7, p. 856, doi. 10.1007/s00535-012-0683-z

By:

Lai, Hsueh-Chou;
Chang, Shih-Ni;
Lin, Che-Chen;
Chen, Ching-Chou;
Chou, Jen-Wei;
Peng, Cheng-Yuan;
Lai, Shih-Wei;
Sung, Fung-Chang;
Li, Yu-Fen

Publication type:

Article

Gallstones, a cholecystectomy, chronic pancreatitis, and the risk of subsequent pancreatic cancer in diabetic patients: a population-based cohort study.

Published in:

Journal of Gastroenterology, 2013, v. 48, n. 6, p. 721, doi. 10.1007/s00535-012-0674-0

By:

Lai, Hsueh-Chou;
Tsai, I-Ju;
Chen, Pei-Chun;
Muo, Chih-Hsin;
Chou, Jen-Wei;
Peng, Cheng-Yuan;
Lai, Shih-Wei;
Sung, Fung-Chang;
Lyu, Shu-Yu;
Morisky, Donald

Publication type:

Article

No Difference in Liver Damage Induced by Isocaloric Fructose or Glucose in Mice with a High-Fat Diet.

Published in:

Nutrients, 2024, v. 16, n. 20, p. 3571, doi. 10.3390/nu16203571

By:

Hsu, Wei-Fan;
Lee, Ming-Hsien;
Lii, Chong-Kuei;
Peng, Cheng-Yuan

Publication type:

Article

Trajectories and Decline of Serum Hepatitis B Surface Antigen Predict Outcomes in Patients With Chronic Hepatitis B.

Published in:

Open Forum Infectious Diseases, 2024, v. 11, n. 12, p. 1, doi. 10.1093/ofid/ofae699

By:

Hsu, Wei-Fan;
Chen, Chuen-Fei;
Lai, Hsueh-Chou;
Su, Wen-Pang;
Wang, Hung-Wei;
Chen, Sheng-Hung;
Huang, Guan-Tarn;
Peng, Cheng-Yuan

Publication type:

Article

Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study.

Published in:

Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac348

By:

Liu, Chen-Hua;
Sun, Hsin-Yun;
Peng, Cheng-Yuan;
Hsieh, Szu-Min;
Yang, Sheng-Shun;
Kao, Wei-Yu;
Shih, Yu-Lueng;
Lin, Chih-Lin;
Liu, Chun-Jen;
Sheng, Wang-Hui;
Lo, Yi-Chun;
Liu, Wen-Chun;
Wu, Jo-Hsuan;
Su, Tung-Hung;
Tseng, Tai-Chung;
Chen, Pei-Jer;
Hung, Chien-Ching;
Kao, Jia-Horng

Publication type:

Article

Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03006-3

By:

Huang, Chung-Feng;
Kuo, Hsing-Tao;
Chang, Te-Sheng;
Lo, Ching-Chu;
Hung, Chao-Hung;
Huang, Chien-Wei;
Chong, Lee-Won;
Cheng, Pin-Nan;
Yeh, Ming-Lun;
Peng, Cheng-Yuan;
Cheng, Chien-Yu;
Huang, Jee-Fu;
Bair, Ming-Jong;
Lin, Chih-Lang;
Yang, Chi-Chieh;
Wang, Szu-Jen;
Hsieh, Tsai-Yuan;
Lee, Tzong-Hsi;
Lee, Pei-Lun;
Wu, Wen-Chih

Publication type:

Article

Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 9, p. 1508, doi. 10.1111/apt.70029

By:

Chang, Yu‐Ping;
Lee, Ji‐Yuh;
Chen, Chi‐Yi;
Kao, Wei‐Yu;
Lin, Chih‐Lin;
Yang, Sheng‐Shun;
Shih, Yu‐Lueng;
Peng, Cheng‐Yuan;
Lee, Fu‐Jen;
Tsai, Ming‐Chang;
Huang, Shang‐Chin;
Su, Tung‐Hung;
Tseng, Tai‐Chung;
Liu, Chun‐Jen;
Chen, Pei‐Jer;
Kao, Jia‐Horng;
Liu, Chen‐Hua

Publication type:

Article

Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks.

Published in:

Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 2, p. 217, doi. 10.1111/apt.17764

By:

Fung, Scott K.;
Pan, Calvin Q.;
Wong, Grace Lai‐Hung;
Seto, Wai‐Kay;
Ahn, Sang Hoon;
Chen, Chi‐Yi;
Hann, Hie‐Won L.;
Jablkowski, Maciej S.;
Kim, Yoon Jun;
Yurdaydin, Cihan;
Peng, Cheng‐Yuan;
Nguyen, Tuan;
Yatsuhashi, Hiroshi;
Flaherty, John F.;
Yee, Leland J.;
Abramov, Frida;
Wang, Hongyuan;
Abdurakhmanov, Dzhamal;
Lim, Young‐Suk;
Buti, Maria

Publication type:

Article

Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir—potential influence of censored observation. Authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 138, doi. 10.1111/apt.17788

By:

Chen, Chien‐Hung;
Peng, Cheng‐Yuan

Publication type:

Article

Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis B.

Published in:

Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 3, p. 334, doi. 10.1111/apt.17602

By:

Chen, Chien‐Hung;
Peng, Cheng‐Yuan;
Hu, Tsung‐Hui;
Wang, Jing‐Houng;
Hung, Chao‐Hung;
Lu, Sheng‐Nan

Publication type:

Article

Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment.

Published in:

Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 4, p. 434, doi. 10.1111/apt.16697

By:

Liu, Chen‐Hua;
Peng, Cheng‐Yuan;
Kao, Wei‐Yu;
Yang, Sheng‐Shun;
Shih, Yu‐Lueng;
Lin, Chin‐Lin;
Tsai, Meng‐Kun;
Lee, Chih‐Yuan;
Chang, Chun‐Chao;
Wu, Jo‐Hsuan;
Liu, Chun‐Jen;
Su, Tung‐Hung;
Tseng, Tai‐Chung;
Chen, Pei‐Jer;
Kao, Jia‐Horng

Publication type:

Article

Editorial: identifying candidates for pegylated interferon add‐on to entecavir therapy in patients with HBeAg‐positive chronic hepatitis B.

Published in:

2019

By:

Peng, Cheng‐Yuan

Publication type:

Editorial

Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan.

Published in:

Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1290, doi. 10.1111/apt.15011

By:

Liu, Chen‐Hua;
Yu, Ming‐Lung;
Peng, Cheng‐Yuan;
Hsieh, Tsai‐Yuan;
Huang, Yi‐Hsiang;
Su, Wei‐Wen;
Cheng, Pin‐Nan;
Lin, Chih‐Lin;
Lo, Ching‐Chu;
Chen, Chi‐Yi;
Chen, Jyh‐Jou;
Ma, Qian;
Brooks‐Rooney, Craig;
Kao, Jia‐Horng

Publication type:

Article

Editorial: a baseline tool for predicting response to peginterferon alfa‐2a in HBeAg‐positive patients—same score, different outcomes.

Published in:

2018

By:

Peng, Cheng‐Yuan

Publication type:

Editorial

Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients.

Published in:

PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0122259

By:

Yeh, Ming-Lun;
Peng, Cheng-Yuan;
Dai, Chia-Yen;
Lai, Hsueh-Chou;
Huang, Chung-Feng;
Hsieh, Ming-Yen;
Huang, Jee-Fu;
Chen, Shinn-Cherng;
Lin, Zu-Yau;
Yu, Ming-Lung;
Chuang, Wan-Long

Publication type:

Article

Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues.

Published in:

Hepatology Research, 2016, v. 46, n. 7, p. 642, doi. 10.1111/hepr.12600

By:

Tseng, Kuo ‐ Chih;
Tseng, Chih ‐ Wei;
Hsieh, Tsai ‐ Yuan;
Peng, Cheng ‐ Yuan;
Lin, Chih ‐ Lin;
Su, Tung ‐ Hung;
Tseng, Tai ‐ Chung;
Lin, Hans Hsienhong;
Wang, Chia ‐ Chi;
Kao, Jia ‐ Horng

Publication type:

Article

Early hepatitis B surface antigen decline predicts treatment response to entecavir in patients with chronic hepatitis B.

Published in:

Scientific Reports, 2017, p. 42879, doi. 10.1038/srep42879

By:

Peng, Cheng-Yuan;
Lai, Hsueh-Chou;
Su, Wen-Pang;
Lin, Chia-Hsin;
Chuang, Po-Heng;
Chen, Sheng-Hung;
Chen, Ching-Hsiang

Publication type:

Article

Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus.

Published in:

Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 7, p. 1323, doi. 10.1111/jgh.13305

By:

Chuang, Wan‐Long;
Chien, Rong‐Nan;
Peng, Cheng‐Yuan;
Chang, Ting‐Tsung;
Lo, Gin‐Ho;
Sheen, I‐Shyan;
Wang, Horng‐Yuan;
Chen, Jyh‐Jou;
Yang, Jenny C.;
Knox, Steven J.;
Gao, Bing;
Garrison, Kimberly L.;
Mo, Hongmei;
Pang, Phillip S.;
Hsu, Yu‐Chun;
Hu, Tsung‐Hui;
Chu, Chi‐Jen;
Kao, Jia‐Horng

Publication type:

Article

Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naïve Taiwanese patients with chronic hepatitis B.

Published in:

Journal of Gastroenterology & Hepatology, 2014, v. 29, n. 1, p. 185, doi. 10.1111/jgh.12416

By:

Chien, Rong‐Nan;
Peng, Cheng‐Yuan;
Kao, Jia‐Horng;
Hu, Tsung‐Hui;
Lin, Chun‐Che;
Hu, Chi‐Tan;
Chen, Chi‐Yi;
Hsieh, Tsai‐Yuan;
Lin, Han‐Chieh;
Chuang, Wan‐Long

Publication type:

Article

Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir.

Published in:

Journal of Gastroenterology & Hepatology, 2013, v. 28, n. 1, p. 46, doi. 10.1111/j.1440-1746.2012.07269.x

By:

Wang, Chia‐Chi;
Tseng, Kuo‐Chih;
Peng, Cheng‐Yuan;
Hsieh, Tsai‐Yuan;
Lin, Chih‐Lin;
Su, Tung‐Hung;
Tseng, Tai‐Chung;
Hsu, Ching‐Sheng;
Lin, Hans Hsienhong;
Kao, Jia‐Horng

Publication type:

Article

Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.

Published in:

Annals of Internal Medicine, 2022, v. 175, n. 9, p. 1221, doi. 10.7326/M21-4119

By:

Grebely, Jason;
Dore, Gregory J.;
Altice, Frederick L.;
Conway, Brian;
Litwin, Alain H.;
Norton, Brianna L.;
Dalgard, Olav;
Gane, Edward J.;
Shibolet, Oren;
Nahass, Ronald;
Luetkemeyer, Anne F.;
Peng, Cheng-Yuan;
Iser, David;
Gendrano, Isaias Noel;
Kelly, Michelle M.;
Hwang, Peggy;
Asante-Appiah, Ernest;
Haber, Barbara A.;
Barr, Eliav;
Robertson, Michael N.

Publication type:

Article

Changes in liver stiffness measurement using acoustic radiation force impulse elastography after antiviral therapy in patients with chronic hepatitis C.

Published in:

PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0190455

By:

Chen, Sheng-Hung;
Lai, Hsueh-Chou;
Chiang, I-Ping;
Su, Wen-Pang;
Lin, Chia-Hsin;
Kao, Jung-Ta;
Chuang, Po-Heng;
Hsu, Wei-Fan;
Wang, Hung-Wei;
Chen, Hung-Yao;
Huang, Guan-Tarn;
Peng, Cheng-Yuan

Publication type:

Article

Drug‐induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan.

Published in:

Liver International, 2021, v. 41, n. 11, p. 2671, doi. 10.1111/liv.14990

By:

Huang, Yi‐Shin;
Wu, Chen‐Yi;
Chang, Ting‐Tsung;
Peng, Cheng‐Yuan;
Lo, Gin‐Ho;
Hsu, Chao‐Wei;
Hu, Chi‐Tan;
Huang, Yi‐Hsiang

Publication type:

Article

On‐treatment predictors of hepatocellular carcinoma in patients with chronic hepatitis B.

Published in:

Liver International, 2021, v. 41, n. 7, p. 1700, doi. 10.1111/liv.14934

By:

Peng, Cheng‐Yuan;
Chen, Chien‐Hung

Publication type:

Article

Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan.

Published in:

Liver International, 2021, v. 41, n. 6, p. 1265, doi. 10.1111/liv.14849

By:

Chen, Chi‐Yi;
Huang, Chung‐Feng;
Cheng, Pin‐Nan;
Tseng, Kuo‐Chih;
Lo, Ching‐Chu;
Kuo, Hsing‐Tao;
Huang, Yi‐Hsiang;
Tai, Chi‐Ming;
Peng, Cheng‐Yuan;
Bair, Ming‐Jong;
Chen, Chien‐Hung;
Yeh, Ming‐Lun;
Lin, Chih‐Lang;
Lin, Chun‐Yen;
Lee, Pei‐Lun;
Chong, Lee‐Won;
Hung, Chao‐Hung;
Huang, Jee‐Fu;
Yang, Chi‐Chieh;
Hu, Jui‐Ting

Publication type:

Article

A combination of the on‐treatment FIB‐4 and alpha‐foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir.

Published in:

Liver International, 2018, v. 38, n. 11, p. 1997, doi. 10.1111/liv.13889

By:

Chiang, Hung‐Hsien;
Lee, Chuan‐Mo;
Hu, Tsung‐Hui;
Hung, Chao‐Hung;
Wang, Jing‐Houng;
Lu, Sheng‐Nan;
Lai, Hsueh‐Chou;
Su, Wen‐Pang;
Lin, Chia‐Hsin;
Peng, Cheng‐Yuan;
Chen, Chien‐Hung

Publication type:

Article

Long‐term follow‐up of clinical trial patients treated for chronic HCV infection with daclatasvir‐based regimens.

Published in:

Liver International, 2018, v. 38, n. 5, p. 821, doi. 10.1111/liv.13596

By:

Reddy, K. Rajender;
Pol, Stanislas;
Thuluvath, Paul J.;
Kumada, Hiromitsu;
Toyota, Joji;
Chayama, Kazuaki;
Levin, James;
Lawitz, Eric J.;
Gadano, Adrian;
Ghesquiere, Wayne;
Gerken, Guido;
Brunetto, Maurizia R.;
Peng, Cheng‐yuan;
Silva, Marcelo;
Strasser, Simone I.;
Heo, Jeong;
Mcphee, Fiona;
Liu, Zhaohui;
Yang, Rong;
Linaberry, Misti

Publication type:

Article

Trajectories of serum hepatitis B surface antigen kinetics in patients with chronic hepatitis B receiving long‐term nucleos(t)ide analogue therapy.

Published in:

Liver International, 2018, v. 38, n. 4, p. 627, doi. 10.1111/liv.13564

By:

Hsu, Wei‐Fan;
Su, Wen‐Pang;
Lin, Chia‐Hsin;
Chuang, Po‐Heng;
Chen, Ching‐Hsiang;
Wang, Hung‐Wei;
Lai, Hsueh‐Chou;
Chen, Sheng‐Hung;
Huang, Guan‐Tarn;
Peng, Cheng‐Yuan;
Chen, Chuen‐Fei

Publication type:

Article

Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.

Published in:

Liver International, 2016, v. 36, n. 12, p. 1755, doi. 10.1111/liv.13253

By:

Su, Tung ‐ Hung;
Hu, Tsung ‐ Hui;
Chen, Chi ‐ Yi;
Huang, Yi ‐ Hsiang;
Chuang, Wan ‐ Long;
Lin, Chun ‐ Che;
Wang, Chia ‐ Chi;
Su, Wei ‐ Wen;
Chen, Ming ‐ Yao;
Peng, Cheng ‐ Yuan;
Chien, Rong ‐ Nan;
Huang, Yi ‐ Wen;
Wang, Horng ‐ Yuan;
Lin, Chih ‐ Lin;
Yang, Sheng ‐ Shun;
Chen, Tsung ‐ Ming;
Mo, Lein ‐ Ray;
Hsu, Shih ‐ Jer;
Tseng, Kuo ‐ Chih;
Hsieh, Tsai ‐ Yuan

Publication type:

Article

All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study.

Published in:

Liver International, 2016, v. 36, n. 10, p. 1433, doi. 10.1111/liv.13128

By:

Kao, Jia‐Horng;
Lee, Youn‐Jae;
Heo, Jeong;
Ahn, Sang‐Hoon;
Lim, Young‐Suk;
Peng, Cheng‐Yuan;
Chang, Ting‐Tsung;
Torbeyns, Anne;
Hughes, Eric;
Bhore, Rafia;
Noviello, Stephanie

Publication type:

Article

A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection.

Published in:

Liver International, 2016, v. 36, n. 8, p. 1101, doi. 10.1111/liv.13082

By:

Kao, Jia ‐ Horng;
Chien, Rong ‐ Nan;
Chang, Ting ‐ Tsung;
Peng, Cheng ‐ Yuan;
Hu, Tsung ‐ Hui;
Lo, Gin ‐ Ho;
Wang, Horng ‐ Yuan;
Chen, Jyh ‐ Jou;
Yang, Jenny C.;
Knox, Steven J.;
Han, Lingling;
Mo, Hongmei;
Mathias, Anita;
Brainard, Diana M.;
Sheen, I ‐ Shyan;
Hsu, Yu ‐ Chun;
Chu, Chi ‐ Jen;
Chuang, Wan ‐ Long

Publication type:

Article

Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis.

Published in:

Liver International, 2016, v. 36, n. 7, p. 954, doi. 10.1111/liv.13049

By:

Kao, Jia ‐ Horng;
Jensen, Donald M.;
Manns, Michael P.;
Jacobson, Ira;
Kumada, Hiromitsu;
Toyota, Joji;
Heo, Jeong;
Yoffe, Boris;
Sievert, William;
Bessone, Fernando;
Peng, Cheng ‐ Yuan;
Roberts, Stuart K.;
Lee, Youn ‐ Jae;
Bhore, Rafia;
Mendez, Patricia;
Hughes, Eric;
Noviello, Stephanie

Publication type:

Article

Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naïve hepatitis B infection patients.

Published in:

Liver International, 2012, v. 32, n. 6, p. 928, doi. 10.1111/j.1478-3231.2011.02742.x

By:

Kao, Jung-Ta;
Lai, Hsueh-Chou;
Tsai, Shu-Mei;
Lin, Pei-Chao;
Chuang, Po-Heng;
Yu, Cheng-Ju;
Cheng, Ken-Sheng;
Su, Wen-Pang;
Hsu, Ping-Ning;
Peng, Cheng-Yuan;
Wu, Yi-Ying

Publication type:

Article

Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis.

Published in:

Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-66182-8

By:

Liu, Chen-Hua;
Peng, Cheng-Yuan;
Fang, Yu-Jen;
Kao, Wei-Yu;
Yang, Sheng-Shun;
Lin, Cheng-Kuan;
Lai, Hsueh-Chou;
Su, Wen-Pang;
Fang, Sheng-Uei;
Chang, Chun-Chao;
Su, Tung-Hung;
Liu, Chun-Jen;
Chen, Pei-Jer;
Chen, Ding-Shinn;
Kao, Jia-Horng

Publication type:

Article

Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study).

Published in:

Infectious Diseases & Therapy, 2025, v. 14, n. 5, p. 1089, doi. 10.1007/s40121-025-01145-y

By:

Huang, Chung-Feng;
Heo, Jeong;
Chien, Rong-Nan;
Baek, Yang-Hyun;
Kao, Jia-Horng;
Kim, Ju-Hyun;
Chang, Ting-Tsung;
Byun, Kwan-Soo;
Chen, Jyh-Jou;
Jeong, Sook-Hyang;
Hu, Tsung-Hui;
Kim, Young-Seok;
Peng, Cheng-Yuan;
Tak, Won-Young;
Wang, Horng-Yuan;
Yoon, Seung-Kew;
Sheen, I.-Shyan;
Youn-Jae Lee;
Hsu, Yu-Chun;
Yim, Hyung-Joon

Publication type:

Article

Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan.

Published in:

Infectious Diseases & Therapy, 2024, v. 13, n. 6, p. 1199, doi. 10.1007/s40121-024-00968-5

By:

Yang, Chun-Chi;
Huang, Chung-Feng;
Chang, Te-Sheng;
Lo, Ching-Chu;
Hung, Chao-Hung;
Huang, Chien-Wei;
Chong, Lee-Won;
Cheng, Pin-Nan;
Yeh, Ming-Lun;
Peng, Cheng-Yuan;
Cheng, Chien-Yu;
Huang, Jee-Fu;
Bair, Ming-Jong;
Lin, Chih-Lang;
Yang, Chi-Chieh;
Wang, Szu-Jen;
Hsieh, Tsai-Yuan;
Lee, Tzong-Hsi;
Lee, Pei-Lun;
Wu, Wen-Chih

Publication type:

Article

Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan.

Published in:

Infectious Diseases & Therapy, 2022, v. 11, n. 1, p. 485, doi. 10.1007/s40121-021-00576-7

By:

Cheng, Pin-Nan;
Mo, Lein-Ray;
Chen, Chun-Ting;
Chen, Chi-Yi;
Huang, Chung-Feng;
Kuo, Hsing-Tao;
Lo, Ching-Chu;
Tseng, Kuo-Chih;
Huang, Yi-Hsiang;
Tai, Chi-Ming;
Peng, Cheng-Yuan;
Bair, Ming-Jong;
Chen, Chien-Hung;
Yeh, Ming-Lun;
Lin, Chih-Lang;
Lin, Chun-Yen;
Lee, Pei-Lun;
Chong, Lee-Won;
Hung, Chao-Hung;
Chang, Te Sheng

Publication type:

Article

The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.

Published in:

Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 10, p. 1901, doi. 10.1111/jgh.15936

By:

Lin, Chih‐Lin;
Tai, Chi‐Ming;
Huang, Jee‐Fu;
Liu, Chun‐Jen;
Chen, Hui‐Fen;
Cheng, Pin‐Nan;
Chen, Chi‐Yi;
Peng, Cheng‐Yuan;
Wang, Chia‐Chi;
Weng, Shih‐Han;
Tseng, Tai‐Chung;
Kao, Jia‐Horng

Publication type:

Article

Long‐term risk of end‐stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan.

Published in:

Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 8, p. 2247, doi. 10.1111/jgh.15469

By:

Hsieh, Meng‐Hsuan;
Bair, Ming‐Jong;
Tsai, Pei‐Chien;
Tseng, Kuo‐Chih;
Lo, Ching‐Chu;
Chen, Chi‐Yi;
Kuo, Hsing‐Tao;
Hung, Chao‐Hung;
Lai, Hsueh‐Chou;
Peng, Cheng‐Yuan;
Wang, Jing‐Houng;
Chen, Jyh‐Jou;
Lee, Pei‐Lun;
Chien, Rong‐Nan;
Yang, Chi‐Chieh;
Lo, Gin‐Ho;
Kao, Jia‐Horng;
Liu, Chun‐Jen;
Liu, Chen‐Hua;
Yan, Sheng‐Lei

Publication type:

Article

Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non‐cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis.

Published in:

Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 11, p. 1977, doi. 10.1111/jgh.14672

By:

Liu, Chen‐Hua;
Shih, Yu‐Lueng;
Yang, Sheng‐Shun;
Lin, Chih‐Lin;
Fang, Yu‐Jen;
Cheng, Pin‐Nan;
Chen, Chi‐Yi;
Peng, Cheng‐Yuan;
Hsieh, Tsai‐Yuan;
Chiu, Yen‐Cheng;
Su, Tung‐Hung;
Liu, Chun‐Jen;
Yang, Hung‐Chih;
Chen, Pei‐Jer;
Chen, Ding‐Shinn;
Kao, Jia‐Horng

Publication type:

Article

Stratification of hepatocellular carcinoma risk through modified FIB‐4 index in chronic hepatitis B patients on entecavir therapy.

Published in:

Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 2, p. 442, doi. 10.1111/jgh.14372

By:

Wang, Hung‐Wei;
Su, Wen‐Pang;
Lin, Chia‐Hsin;
Chuang, Po‐Heng;
Lai, Hsueh‐Chou;
Peng, Cheng‐Yuan;
Hu, Tsung‐Hui;
Lu, Sheng‐Nan;
Hung, Chao‐Hung;
Wang, Jing‐Houng;
Chen, Chien‐Hung;
Lee, Mei‐Hsuan

Publication type:

Article

Twelve‐week ravidasvir plus ritonavir‐boosted danoprevir and ribavirin for non‐cirrhotic HCV genotype 1 patients: A phase 2 study.

Published in:

Journal of Gastroenterology & Hepatology, 2018, v. 33, n. 8, p. 1507, doi. 10.1111/jgh.14096

By:

Kao, Jia‐Horng;
Yu, Min‐Lung;
Chen, Chi‐Yi;
Peng, Cheng‐Yuan;
Chen, Ming‐Yao;
Tang, Huoling;
Chen, Qiaoqiao;
Wu, Jinzi J.

Publication type:

Article

Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1.

Published in:

Journal of Gastroenterology & Hepatology, 2017, v. 32, n. 12, p. 1998, doi. 10.1111/jgh.13796

By:

Kao, Jia‐Horng;
Yu, Ming‐Lung;
Peng, Cheng‐Yuan;
Heo, Jeong;
Chu, Chi‐Jen;
Chang, Ting‐Tsung;
Lee, Youn‐Jae;
Hu, Tsung‐Hui;
Yoon, Ki Tae;
Paik, Seung Woon;
Lim, Young Suk;
Ahn, Sang Hoon;
Isakov, Vasily;
McPhee, Fiona;
Hu, Wenhua;
Scott Swenson, Eugene;
Yin, Philip D;
Treitel, Michelle

Publication type:

Article

Modified Albumin–Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy.

Published in:

Cancers, 2022, v. 14, n. 20, p. 5083, doi. 10.3390/cancers14205083

By:

Hsu, Wei-Fan;
Hsu, Shih-Chao;
Chen, Te-Hong;
Lin, Chien-Hung;
Lin, Ying-Chun;
Chang, Yu-Wei;
Wang, Hung-Wei;
Liao, Yu-Min;
Lai, Hsueh-Chou;
Peng, Cheng-Yuan

Publication type:

Article

A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy.

Published in:

Cancers, 2022, v. 14, n. 20, p. 5063, doi. 10.3390/cancers14205063

By:

Chen, Chien-Hung;
Hu, Tsung-Hui;
Wang, Jing-Houng;
Lai, Hsueh-Chou;
Hung, Chao-Hung;
Lu, Sheng-Nan;
Peng, Cheng-Yuan

Publication type:

Article

On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma.

Published in:

Cancers, 2021, v. 13, n. 15, p. 3758, doi. 10.3390/cancers13153758

By:

Wang, Hung-Wei;
Chuang, Po-Heng;
Su, Wen-Pang;
Kao, Jung-Ta;
Hsu, Wei-Fan;
Lin, Chun-Che;
Huang, Guan-Tarn;
Lin, Jaw-Town;
Lai, Hsueh-Chou;
Peng, Cheng-Yuan

Publication type:

Article

On-Treatment Changes in FIB-4 and 1-Year FIB-4 Values Help Identify Patients with Chronic Hepatitis B Receiving Entecavir Therapy Who Have the Lowest Risk of Hepatocellular Carcinoma.

Published in:

Cancers, 2020, v. 12, n. 5, p. 1177, doi. 10.3390/cancers12051177

By:

Wang, Hung-Wei;
Lai, Hsueh-Chou;
Hu, Tsung-Hui;
Su, Wen-Pang;
Lu, Sheng-Nan;
Lin, Chia-Hsin;
Hung, Chao-Hung;
Chuang, Po-Heng;
Wang, Jing-Houng;
Lee, Mei-Hsuan;
Chen, Chien-Hung;
Peng, Cheng-Yuan

Publication type:

Article

Real‐world efficacy and safety of universal 8‐week glecaprevir/pibrentasvir in patients with chronic hepatitis C with early chronic kidney disease or pre‐end‐stage renal disease: Insights from a nationwide hepatisis C virus registry in Taiwan

Published in:

Kaohsiung Journal of Medical Sciences, 2025, v. 41, n. 2, p. 1, doi. 10.1002/kjm2.12929

By:

Wang, Szu‐Jen;
Huang, Chung‐Feng;
Chang, Te‐Sheng;
Lo, Ching‐Chu;
Hung, Chao‐Hung;
Huang, Chien‐Wei;
Chong, Lee‐Won;
Cheng, Pin‐Nan;
Yeh, Ming‐Lun;
Peng, Cheng‐Yuan;
Cheng, Chien‐Yu;
Huang, Jee‐Fu;
Bair, Ming‐Jong;
Lin, Chih‐Lang;
Yang, Chi‐Chieh;
Kuo, Hsing‐Tao;
Hsieh, Tsai‐Yuan;
Lee, Tzong‐Hsi;
Lee, Pei‐Lun;
Wu, Wen‐Chih

Publication type:

Article

Ultrasound-Based Liver Stiffness Surveillance in Patients Treated for Chronic Hepatitis B or C.

Published in:

Applied Sciences (2076-3417), 2018, v. 8, n. 4, p. 626, doi. 10.3390/app8040626

By:

Chen, Sheng-Hung;
Peng, Cheng-Yuan

Publication type:

Article